Literature DB >> 4735001

Radioimmunoassay of triiodothyronine in unextracted human serum.

R D Hesch, D Evered.   

Abstract

Serum triiodothyronine (T-3) concentrations have been estimated by radioimmunoassay using unextracted serum. The serum T-3 concentrations have been shown to be similar in two separate European populations (0.76-1.67 ng/ml). Raised T-3 values have been observed in all subjects with hyperthyroidism. Low values are seen in hypothyroidism although there is some overlap with the normal range. There is a good correlation between serum T-3 and serum thyroxine (T-4) concentrations, and estimation of T-3 seems likely to prove a practical and reliable test of thyroid function.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4735001      PMCID: PMC1588630          DOI: 10.1136/bmj.1.5854.645

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

Review 1.  Hypothyroidism.

Authors:  D Evered; R Hall
Journal:  Br Med J       Date:  1972-01-29

2.  Thyrotrophin-releasing hormone as a thyroid-function test.

Authors:  B J Ormston; R J Cryer; R Garry; G M Besser; R Hall
Journal:  Lancet       Date:  1971-07-03       Impact factor: 79.321

3.  Specific antibodies to triiodothyronine hormone.

Authors:  B L Brown; R P Ekins; S M Ellis; W S Reith
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

4.  Technical aspects of the estimation of triiodothyronine in human serum: evidence of conversion of thyroxine to triiodothyronine during assay.

Authors:  P R Larsen
Journal:  Metabolism       Date:  1971-06       Impact factor: 8.694

5.  Serum triiodothyronine: measurements in human serum by radioimmunoassay with corroboration by gas-liquid chromatography.

Authors:  T Mitsuma; N Nihei; M C Gershengorn; C S Hollander
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

6.  Salicylate-induced increases in free triiodothyronine in human serum. Evidence of inhibition of triiodothyronine binding to thyroxine-binding globulin and thyroxine-binding prealbumin.

Authors:  P R Larsen
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

7.  Direct immunoassay of triiodothyronine in human serum.

Authors:  P R Larsen
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

8.  Determination of triiodothyronine concentration in human serum.

Authors:  K Sterling; D Bellabarba; E S Newman; M A Brenner
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

9.  Inhibition of triiodothyronine (T3) binding to thyroxine-binding globulin by sodium salicylate and its application to immunoassay of T3 in human serum.

Authors:  P R Larsen
Journal:  Metabolism       Date:  1971-10       Impact factor: 8.694

10.  Radioimmunoassay for measurement of triiodothyronine in human serum.

Authors:  I J Chopra; D H Solomon; G N Beall
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

View more
  12 in total

1.  Assessment of thyroid hormone assays.

Authors:  D C Evered; P A Vice; E Green; D Appleton
Journal:  J Clin Pathol       Date:  1976-12       Impact factor: 3.411

2.  Serum thyrotrophin determination on day 5 of life as screening procedure for congenital hypothyroidism.

Authors:  F Delange; M Camus; M Winkler; J Dodion; A M Ermans
Journal:  Arch Dis Child       Date:  1977-02       Impact factor: 3.791

3.  Indication for operation of patients with autonomously functioning thyroid tissue in endemic goiter areas.

Authors:  P E Goretzki; R A Wahl; D Branscheid; K Joseph; A Tsuchiya; H D Röher
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

4.  Pituitary-adrenal and pituitary-thyroid function during administration of difluocortolone and dexamethasone to human subjects.

Authors:  R F Lambe; D A O'Kelly; A Darragh
Journal:  Ir J Med Sci       Date:  1978-01       Impact factor: 1.568

5.  Ophthalmic Graves's disease: natural history and detailed thyroid function studies.

Authors:  C S Teng; P P Yeo
Journal:  Br Med J       Date:  1977-01-29

6.  Anticonvulsants and thyroid function.

Authors:  P P Yeo; D Bates; J G Howe; W A Ratcliffe; C W Schardt; A Heath; D C Evered
Journal:  Br Med J       Date:  1978-06-17

7.  Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone.

Authors:  D Carr; A Gomez-Pan; D R Weightman; V C Roy; R Hall; G M Besser; M O Thorner; A S McNeilly; A V Schally; A J Kastin; D H Coy
Journal:  Br Med J       Date:  1975-07-12

8.  Treatment of hypothyroidism: a reappraisal of thyroxine therapy.

Authors:  D Evered; E T Young; B J Ormston; R Menzies; P A Smith; R Hall
Journal:  Br Med J       Date:  1973-07-21

9.  The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia.

Authors:  R W Prescott; D G Johnston; P K Taylor; J Haigh; D R Weightman; K Hall; D B Cook
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

10.  Thyrotropin secreting pituitary tumours: a cause of hyperthyroidism.

Authors:  I S Salti; N Nuwayri-Salti; R A Bergman; S I Nassar; K F Muakkasah; I Fakhri-Sahli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.